Oligodendrogenesis in the normal and pathological central nervous system
Oligodendrocytes (OLGs) are generated late in development and myelination is thus a
tardive event in the brain developmental process. It is however maintained whole life long at …
tardive event in the brain developmental process. It is however maintained whole life long at …
[HTML][HTML] Mechanism-based approaches of 1, 3, 4 thiadiazole scaffolds as potent enzyme inhibitors for cytotoxicity and antiviral activity
Significant progress in understanding cancer pathogenesis, it remains one of the leading
causes of death after cardiovascular diseases. Similarly viral infections have emerged from …
causes of death after cardiovascular diseases. Similarly viral infections have emerged from …
[PDF][PDF] Collaborative study report on blood coagulation factor IX: Expert Committee on Biological Standardization: Geneva, 12 to 16 October 2015
World Health Organization… - 2015 - apps.who.int
There are three main aims for this collaborative study: 1. to add a FIX antigen value to the 4
th International Standard for Blood Coagulation Factors II, VII, IX and X, Plasma, Human …
th International Standard for Blood Coagulation Factors II, VII, IX and X, Plasma, Human …
Dimethyl fumarate selectively reduces memory T cells and shifts the balance between Th1/Th17 and Th2 in multiple sclerosis patients
QI Wu, Q Wang, G Mao, CA Dowling… - The Journal of …, 2017 - journals.aai.org
Dimethyl fumarate (DMF; trade name Tecfidera) is an oral formulation of the fumaric acid
ester that is Food and Drug Administration approved for treatment of relapsing-remitting …
ester that is Food and Drug Administration approved for treatment of relapsing-remitting …
How I manage Evans syndrome and AIHA cases in children
M Miano - British journal of haematology, 2016 - Wiley Online Library
Summary The management of Evans Syndrome in children is challenging due to the lack of
evidence‐based data on treatment. Steroids, the first‐choice therapy, are successful in …
evidence‐based data on treatment. Steroids, the first‐choice therapy, are successful in …
The neurobiology of HIV and its impact on cognitive reserve: A review of cognitive interventions for an aging population
SL Cody, DE Vance - Neurobiology of disease, 2016 - Elsevier
The medications used to treat HIV have reduced the severity of cognitive deficits; yet, nearly
half of adults with HIV still exhibit some degree of cognitive deficits, referred to as HIV …
half of adults with HIV still exhibit some degree of cognitive deficits, referred to as HIV …
[PDF][PDF] John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy
V Pietropaolo, C Prezioso, F Bagnato… - New …, 2018 - newmicrobiologica.org
JCV is a small (∼ 45 nm), non-enveloped, circular, double-stranded DNA genome,
arranged in 72 viral capsomeres with icosahedral symmetry (Tan et al., 2009a). The genome …
arranged in 72 viral capsomeres with icosahedral symmetry (Tan et al., 2009a). The genome …
Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS)
J Bauer, R Gold, O Adams, H Lassmann - Acta neuropathologica, 2015 - Springer
Progressive multifocal leukoencephalopathy is a viral encephalitis induced by the John
Cunningham (JC) virus, an ubiquitous neurotropic papovavirus of the genus polyomavirus …
Cunningham (JC) virus, an ubiquitous neurotropic papovavirus of the genus polyomavirus …
Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis
R Hoepner, S Faissner, A Salmen… - Journal of central …, 2014 - journals.sagepub.com
Natalizumab (Nat) is a humanized monoclonal antibody used for the treatment of relapsing
multiple sclerosis (MS). Nat inhibits lymphocyte migration via the blood brain barrier (BBB) …
multiple sclerosis (MS). Nat inhibits lymphocyte migration via the blood brain barrier (BBB) …
CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS
V Limmroth, F Barkhof, N Desem, MP Diamond… - Neurology, 2014 - AAN Enterprises
Objective: This study evaluated the efficacy and safety of ATL1102, an antisense
oligonucleotide that selectively targets the RNA for human CD49d, the α subunit of very late …
oligonucleotide that selectively targets the RNA for human CD49d, the α subunit of very late …